Literature DB >> 19052079

A conserved domain in the leader proteinase of foot-and-mouth disease virus is required for proper subcellular localization and function.

Teresa de los Santos1, Fayna Diaz-San Segundo, James Zhu, Marla Koster, Camila C A Dias, Marvin J Grubman.   

Abstract

The leader proteinase (L(pro)) of foot-and-mouth disease virus (FMDV) is involved in antagonizing the innate immune response by blocking the expression of interferon (IFN) and by reducing the immediate-early induction of IFN-beta mRNA and IFN-stimulated genes. In addition to its role in shutting off cap-dependent host mRNA translation, L(pro) is associated with the degradation of the p65/RelA subunit of nuclear factor kappaB (NF-kappaB). Bioinformatics analysis suggests that L(pro) contains a SAP (for SAF-A/B, Acinus, and PIAS) domain, a protein structure associated in some cases with the nuclear retention of molecules involved in transcriptional control. We have introduced a single or a double mutation in conserved amino acid residues contained within this domain of L(pro). Although three stable mutant viruses were obtained, only the double mutant displayed an attenuated phenotype in cell culture. Indirect immunofluorescence analysis showed that L(pro) subcellular distribution is altered in cells infected with the double mutant virus. Interestingly, nuclear p65/RelA staining disappeared from wild-type (WT) FMDV-infected cells but not from double mutant virus-infected cells. Consistent with these results, NF-kappaB-dependent transcription was not inhibited in cells infected with double mutant virus in contrast to cells infected with WT virus. However, degradation of the translation initiation factor eIF-4G was very similar for both the WT and the double mutant viruses. Since L(pro) catalytic activity was demonstrated to be a requirement for p65/RelA degradation, our results indicate that mutation of the SAP domain reveals a novel separation-of-function activity for FMDV L(pro).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19052079      PMCID: PMC2643771          DOI: 10.1128/JVI.02112-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase.

Authors:  J Chinsangaram; M Koster; M J Grubman
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  The mengovirus leader protein suppresses alpha/beta interferon production by inhibition of the iron/ferritin-mediated activation of NF-kappa B.

Authors:  Jan Zoll; Willem J G Melchers; Jochem M D Galama; Frank J M van Kuppeveld
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

3.  The leader protein of Theiler's virus interferes with nucleocytoplasmic trafficking of cellular proteins.

Authors:  Sophie Delhaye; Vincent van Pesch; Thomas Michiels
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

4.  A transcriptional corepressor of Stat1 with an essential LXXLL signature motif.

Authors:  B Liu; M Gross; J ten Hoeve; K Shuai
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

5.  Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon.

Authors:  J Chinsangaram; M E Piccone; M J Grubman
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  SAF-Box, a conserved protein domain that specifically recognizes scaffold attachment region DNA.

Authors:  M Kipp; F Göhring; T Ostendorp; C M van Drunen; R van Driel; M Przybylski; F O Fackelmayer
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

7.  Dimethylfumarate inhibits TNF-induced nuclear entry of NF-kappa B/p65 in human endothelial cells.

Authors:  Robert Loewe; Wolfgang Holnthoner; Marion Gröger; Manuela Pillinger; Florian Gruber; Diana Mechtcheriakova; Erhard Hofer; Klaus Wolff; Peter Petzelbauer
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

8.  The 'PINIT' motif, of a newly identified conserved domain of the PIAS protein family, is essential for nuclear retention of PIAS3L.

Authors:  D Duval; G Duval; C Kedinger; O Poch; H Boeuf
Journal:  FEBS Lett       Date:  2003-11-06       Impact factor: 4.124

Review 9.  Evading the host immune response: how foot-and-mouth disease virus has become an effective pathogen.

Authors:  Marvin J Grubman; Mauro Pires Moraes; Fayna Diaz-San Segundo; Lindomar Pena; Teresa de los Santos
Journal:  FEMS Immunol Med Microbiol       Date:  2008-04-08

10.  Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine.

Authors:  Mauro P Moraes; Jarasvech Chinsangaram; Mario C S Brum; Marvin J Grubman
Journal:  Vaccine       Date:  2003-12-12       Impact factor: 3.641

View more
  35 in total

1.  Inoculation of swine with foot-and-mouth disease SAP-mutant virus induces early protection against disease.

Authors:  Fayna Díaz-San Segundo; Marcelo Weiss; Eva Pérez-Martín; Camila C Dias; Marvin J Grubman; Teresa de los Santos
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

2.  Porcine Reproductive and Respiratory Syndrome Virus Nonstructural Protein 1 Beta Interacts with Nucleoporin 62 To Promote Viral Replication and Immune Evasion.

Authors:  Hanzhong Ke; Mingyuan Han; Jineui Kim; Kurt E Gustin; Dongwan Yoo
Journal:  J Virol       Date:  2019-06-28       Impact factor: 5.103

3.  Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling.

Authors:  Dang Wang; Liurong Fang; Kui Li; Huijuan Zhong; Jinxiu Fan; Chao Ouyang; Huan Zhang; Erzhen Duan; Rui Luo; Zhongming Zhang; Xiangtao Liu; Huanchun Chen; Shaobo Xiao
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

4.  Residues within the Foot-and-Mouth Disease Virus 3Dpol Nuclear Localization Signal Affect Polymerase Fidelity.

Authors:  Anna Kloc; Devendra K Rai; Douglas P Gladue; Elizabeth Schafer; Mary Kenney; Elizabeth Rieder
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

5.  The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase.

Authors:  Dang Wang; Liurong Fang; Ping Li; Li Sun; Jinxiu Fan; Qingye Zhang; Rui Luo; Xiangtao Liu; Kui Li; Huanchun Chen; Zhongbin Chen; Shaobo Xiao
Journal:  J Virol       Date:  2011-02-09       Impact factor: 5.103

6.  Foot-and-mouth disease virus leader proteinase inhibits dsRNA-induced RANTES transcription in PK-15 cells.

Authors:  Dang Wang; Liurong Fang; Jing Bi; Quangang Chen; Lu Cao; Rui Luo; Huanchun Chen; Shaobo Xiao
Journal:  Virus Genes       Date:  2011-03-12       Impact factor: 2.332

7.  RNA structural domains in noncoding regions of the foot-and-mouth disease virus genome trigger innate immunity in porcine cells and mice.

Authors:  Miguel Rodríguez-Pulido; Belén Borrego; Francisco Sobrino; Margarita Sáiz
Journal:  J Virol       Date:  2011-04-27       Impact factor: 5.103

8.  Differential gene expression in porcine SK6 cells infected with wild-type and SAP domain-mutant foot-and-mouth disease virus.

Authors:  Zixin Ni; Fan Yang; Weijun Cao; Xiangle Zhang; Ye Jin; Ruoqing Mao; Xiaoli Du; Weiwei Li; Jianhong Guo; Xiangtao Liu; Zixiang Zhu; Haixue Zheng
Journal:  Virol Sin       Date:  2016-04-08       Impact factor: 4.327

9.  Synonymous Deoptimization of Foot-and-Mouth Disease Virus Causes Attenuation In Vivo while Inducing a Strong Neutralizing Antibody Response.

Authors:  Fayna Diaz-San Segundo; Gisselle N Medina; Elizabeth Ramirez-Medina; Lauro Velazquez-Salinas; Marla Koster; Marvin J Grubman; Teresa de los Santos
Journal:  J Virol       Date:  2015-11-18       Impact factor: 5.103

Review 10.  The leader proteinase of foot-and-mouth disease virus: structure-function relationships in a proteolytic virulence factor.

Authors:  Jutta Steinberger; Tim Skern
Journal:  Biol Chem       Date:  2014-10       Impact factor: 3.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.